Bafna Pharmaceuticals Board Meeting on Nov 11, 2026

Bafna Pharmaceuticals Ltd has announced that its Board of Directors will convene on November 11, 2026. The primary agenda item for this meeting is to consider and approve the Un-Audited Financial Results for the Quarter and Half-Year ended September 30, 2026. In line with SEBI regulations and the company's insider trading code, the trading window for designated persons and their relatives will remain closed from October 1, 2026, to November 13, 2026, inclusive. This closure is to prevent any potential insider trading during the sensitive period leading up to the financial results announcement.